Poultry Pharmaceuticals Market
完整報告名稱與涵蓋範圍
Poultry Pharmaceuticals Market Size, Share & Trends Analysis Report By Product Type (Drugs (Vetrimoxin, Other drug products), Vaccines (Innovax, Nobilis, Poulvac, Other vaccine products), Feed Additives (VIGOSINE, Amnovit, Other feed additives)), By Animal Type, By Region, And By Segment Forecasts, 2023-2031.
報告摘要
In 2022, the Poultry Pharmaceuticals Market worldwide was assessed at USD 6.72 Bn. Analysts project it will surge to USD 14.03 Bn by 2031, at a CAGR of 8.68% spanning 2023 to 2031.
At its core, Poultry Pharmaceuticals pertains to landscape are expandingly turning to these solutions to meet contemporary demands.
Several factors contribute to this trajectory, including heightened appetite for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold meaningful shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Poultry Pharmaceuticals Market Snapshot
Chapter 4. Global Poultry Pharmaceuticals Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type, & Market Share, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product Type:
5.2.1. Drugs
5.2.1.1. VETRIMOXIN
5.2.1.2. Other Drug Products
5.2.2. Vaccines
5.2.2.1. INNOVAX
5.2.2.2. NOBILIS
5.2.2.3. Poulvac
5.2.2.4. Other Vaccine Products
5.2.3. Feed Additives
5.2.3.1. VIGOSINE
5.2.3.2. Amnovit
5.2.3.3. Other Feed Additives
Chapter 6. Market Segmentation 2: By Animal Type Estimates & Trend Analysis
6.1. By Animal Type & Market Share, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Animal Type:
6.2.1. Chicken
6.2.2. Turkey
6.2.3. Duck
6.2.4. Goose
6.2.5. Others
7.1. Global Poultry Pharmaceuticals Market , Regional Snapshot 2023 & 2031
7.2. North America
Chapter 7. Poultry Pharmaceuticals Market Segmentation 3: Regional Estimates & Trend Analysis
7.2.1. North America Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
7.2.1.1. US
7.2.1.2. Canada
7.2.2. North America Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031
7.2.3. North America Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Product type, 2024-2031
7.3. Europe
7.3.1. Europe Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
7.3.1.1. Germany
7.3.1.2. U.K.
7.3.1.3. France
7.3.1.4. Italy
7.3.1.5. Spain
7.3.1.6. Rest of Europe
7.3.2. Europe Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031
7.3.3. Europe Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Product type, 2024-2031
7.4. Asia Pacific
7.4.1. Asia Pacific Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
7.4.1.1. India
7.4.1.2. China
7.4.1.3. Japan
7.4.1.4. Australia
7.4.1.5. South Korea
7.4.1.6. Hong Kong
7.4.1.7. Southeast Asia
7.4.1.8. Rest of Asia Pacific
7.4.2. Asia Pacific Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031
7.4.3. Asia Pacific Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts By Product type, 2024-2031
7.5. Latin America
7.5.1. Latin America Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
7.5.1.1. Brazil
7.5.1.2. Mexico
7.5.1.3. Rest of Latin America
7.5.2. Latin America Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031
7.5.3. Latin America Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Product type, 2024-2031
7.6. Middle East & Africa
7.6.1. Middle East & Africa Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.6.1.1. GCC Countries
7.6.1.2. Israel
7.6.1.3. South Africa
7.6.1.4. Rest of Middle East and Africa
7.6.2. Middle East & Africa Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031
7.6.3. Middle East & Africa Poultry Pharmaceuticals Market Revenue (US$ Million) Estimates and Forecasts by Product type, 2024-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Aervoe Industries Inc.
8.2.1.1. Business Overview
8.2.1.2. Key Product/Service Overview
8.2.1.3. Financial Performance
8.2.1.4. Geographical Presence
8.2.1.5. Recent Developments with Business Strategy
8.2.2. Bayer AG,
8.2.3. Bimeda
8.2.4. Ceva Sante Animale
8.2.5. Elanco Animal Health (Eli Lilly and Company)
8.2.6. Merck Animal Health
8.2.7. Merial Animal Health (Sanofi)
8.2.8. Virbac
8.2.9. Boehringer Ingelheim
8.2.10. Zoetis, Inc.
8.2.11. Pacific GeneTech
8.2.12. Avivagen Inc.
8.2.13. Hester Biosciences Limited
8.2.14. Venkys India
8.2.15. Calier
8.2.16. KM Biologics
8.2.17. Others
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們